Background: Accumulating evidence suggests that posttraumatic stress disorder (PTSD) is associated with disrupted default mode network (DMN) connectivity, but findings across studies have not been uniform. Individual differences in relevant genes may account for some of the reported variability in the relationship between DMN connectivity and PTSD. In this study, we investigated this possibility using genome-wide association study (GWAS) derived polygenic risk scores (PRSs) for relevant psychiatric traits. We hypothesized that the association between PTSD and DMN connectivity would be moderated by genetic risk for one or more psychiatric traits such that individuals with elevated polygenic risk for psychopathology and severe PTSD would exhibit disrupted DMN connectivity.
associated with disrupted connectivity of the default mode network (DMN; Koch et al., 2016; Patel, Spreng, Shin, & Girard, 2012; Sripada et al., 2012) . The DMN is an intrinsic functional connectivity network that is engaged primarily at rest or during internally directed tasks such as mind-wandering, autobiographical memory, future thinking, self-mentalizing, and social processing of the self and others (AndrewsHanna, Reidler, Sepulcre, Poulin, & Buckner, 2010; Andrews-Hanna, Smallwood, & Spreng, 2014; Gusnard, Akbudak, Shulman, & Raichle, 2001; Spreng & Grady, 2010) . Its primary regions include the posterior cingulate cortex (PCC), medial prefrontal cortex, hippocampus, angular gyrus, and lateral temporal cortex ).
Rs-fMRI has attracted considerable interest from clinical neuroscientists as a paradigm for studying associations between psychopathology and perturbations of the functional neural connectome. Several prior rs-fMRI studies have shown PTSD to be associated with reduced functional connectivity in the DMN, suggesting the predominance of externally focused and vigilant neural activity during rest (Bluhm et al., 2009; Kennis, van Rooij, van den Heuvel, Kahn, & Geuze, 2016; Koch et al., 2016; Qin et al., 2012; Sripada et al., 2012; Zhou et al., 2012 ).
However, findings across studies have not been consistent, with some studies reporting positive or no associations between DMN connectivity and PTSD (Lanius et al., 2010; Patel et al., 2012; Reuveni et al., 2016) . One possible source of variability in results across studies are genetic factors that influence functional connectivity (Glahn et al., 2010; Sheline et al., 2010; Wiggins et al., 2012; Wiggins et al., 2013) .
For example, Miller et al. (2016) recently found that serotonin receptor single nucleotide polymorphisms (SNPs) significantly moderated the relationship between PTSD and functional connectivity, whereby PTSD symptom severity was negatively associated with DMN connectivity between the PCC and right middle temporal gyrus only among patients homozygous for risk variants in the serotonin receptor gene
HTR2A.
The aim of this study was to expand our search for genetic factors that moderate the association between PTSD and DMN connectivity using polygenic risk scores (PRSs). PRSs are derived from results of large-scale consortia-based genome-wide association studies (GWASs). They are summary measures of the additive effect of hundreds of thousands or millions of SNPs from across the entire genome and provide an index of an individual's genetic propensity for the GWAS trait. PRSs are computed by taking SNPs with significance levels at and below a specified P-value threshold from the GWAS, weighting each SNP for each individual in an independent dataset based on its effect size from the GWAS, and then summing across the SNPs. The resulting PRS can be thought of as an individual's genetic "risk" for the phenotype evaluated in the GWAS, with higher scores indicating greater genetic liability. PRSs have been shown to explain a larger proportion of the variance in the phenotype than SNPs from candidate genes or even peak SNPs from GWAS studies (Chatterjee, Shi, & García-Closas, 2016; Ridge, Mukherjee, Crane, & Kauwe, 2013) .
It is now well-established that risk for PTSD is influenced by genetic factors that are not unique to PTSD, but rather, shared with genetic risk for other psychiatric disorders such as major depression (Koenen et al., 2008; Sartor et al., 2012; Solovieff et al., 2014) and anxiety (Chantarujikapong et al., 2001) . For example, Solovieff et al. (2014) found that polygenic risk for depression was associated with PTSD symptom severity. In another study, using data from a twin study of Vietnam veterans, Wolf et al. (2010) modeled the relative strength of genetic and environmental influences on the common factors underlying PTSD and the internalizing and externalizing spectra of psychopathology. Analyses revealed that 41% of the variance in the internalizing latent variable was accounted for by one genetic factor, whereas a second, distinct, genetic factor explained 40% of the variance in the externalizing latent variable. PTSD was primarily associated with the internalizing spectrum. Based on this pattern of results, the authors concluded that the first genetic factor likely corresponded conceptually to the inherited/temperamental component of trait negative emotionality/neuroticism (i.e., the primary personality substrate for the internalizing disorders), which has also been implicated in other research as the primary temperamental vulnerability for PTSD (Breslau & Schultz, 2013; Miller, 2003; Miller, Grief, & Smith, 2003; Miller, Kaloupek, Dillon, & Keane, 2004) .
Similarly, the Cross-Disorder Group of the Psychiatric Genomics Consortium (PGC; 2013) examined shared genetic vulnerability across five psychiatric disorders: major depressive disorder, bipolar disorder, schizophrenia, autism spectrum disorder, and attention hyperactivity deficit disorder. Results suggested genetic commonalities between the three adult disorders (i.e., major depressive disorder, bipolar disorder, and schizophrenia) and between autism spectrum disorder, schizophrenia, and bipolar disorder. In another study, Bulik-Sullivan et al. (2015) examined shared genetic vulnerabilities across 24 psychiatric traits and found genetic commonalities between anorexia nervosa, obesity, schizophrenia, major depressive disorder, and/or bipolar disorder (among others).
The goal of this study was to leverage the scientific and statistical power of the genome-wide PRSs derived from these studies to advance understanding of the relationship between PTSD and a putative neural endophenotype of the condition, disrupted DMN connectivity. Although there is strong evidence for an association between disruptions in DMN connectivity and PTSD, there is minimal research that examines the link between PRSs and PTSD or DMN connectivity (see Supporting Information Table S1 for additional details). However, as suggested by the foregoing twin, personality, and molecular genetic GWAS study findings, there is support for shared genetic risk across psychiatric disorders and in particular, genetic commonalities between PTSD and neuroticism, anxiety, and depression. As such, we focused on polygenic scores for neuroticism, anxiety, major depressive disorder, and cross-disorder risk, and evaluated the hypothesis that the association between PTSD and DMN connectivity would be moderated by PRSs for one or more of these traits. Moreover, given the high rate of comorbidity between PTSD and mild traumatic brain injury (mTBI) in this cohort, and prior evidence for an association between mTBI and DMN connectivity (Johnson et al., 2012; Vakhtin et al., 2013) , we also examined the potential influence of this comorbid condition. Fifty-five percent of the sample met DSM-IV criteria for current PTSD (symptom severity M/SD = 44.1/27.6). Table 1 includes medication information for the sample.
TA B L E 1 Medication information of sample
Exclusionary criteria included history of seizures unrelated to head injury, vascular disease, heart conditions, serious mental illness such as bipolar disorder or other psychotic disorders, active suicidal or homicidal ideation, cognitive disorder due to a general medical condition, and incompatibility with MRI due to ferromagnetic objects or pregnancy.
All study procedures were reviewed and approved by the local Institutional Review Board.
Clinical and demographic assessment
PTSD symptom severity was assessed with the Clinician-Administered PTSD Scale (CAPS) for DSM-IV (Blake et al., 1995) and diagnoses were confirmed via consensus of three doctoral level psychologists.
For the purposes of this study, we analyzed a continuous measure of PTSD symptom severity within the last 30 days prior to the assessment. The CAPS is a structured interview that assesses each DSM-IV PTSD symptom with two items that reflect the frequency and intensity of symptoms (each on a 0-4 scale) with higher scores indicative of greater symptom severity. TBI was evaluated with the Boston 
MRI Acquisition and processing
Imaging data were acquired on a 3 T Siemens TIM Trio scanner with a 12-channel head coil. Two Magnetization Prepared Rapid Gradient Echo (MP-RAGE) T1-weighted structural scans were acquired with the following parameters: TR = 2,530, TE = 3.32 ms, flip angle = 7°, 1 × 1 × 1 mm 3 voxels. These structural scans were averaged to create a single high contrast-to-noise image and were further used in surface reconstruction, functional connectivity seed placement, and registration.
During the same session, two 6-min rs-fMRI scans were collected using the following parameters: gradient echo echo-planar imaging, TR = 3,000, TE = 30 ms, flip angle = 90°, 3 × 3 × 3.75 mm 3 voxels, 38 slices.
Participants were instructed to keep their eyes open and stay awake during rs-fMRI data collection.
Data were processed using a combination of FreeSurfer (Fig. 1B) .
Genotyping
Generation of the genotype data for the TRACTS cohort, including DNA extraction, genotyping, and data cleaning, has been described in detail elsewhere (Miller et al., 2015) , and will only be summarized briefly here. DNA was isolated from peripheral blood samples hybridized to Illumina HumanOmni2.5-8 microarrays (Illumina, San Diego, CA) according to manufacturer's protocol and imaged using the Illumina iScan System. Samples for which the call rate was <0.99
were repeated. In the resulting data, all individuals had call rates >0.994, and all samples passed a concordance check between sex and X chromosome homozygosity performed in PLINK v1.07 (Purcell et al., 2007) . Ancestry was confirmed by a principal component analysis 
PRS calculation
Polygenic scores for neuroticism, anxiety, major depressive disorder, and cross-disorder risk were calculated using results from published GWAS studies. The PRSs for neuroticism, anxiety, and major depressive disorder were based on the GWAS meta-analysis of neuroticism conducted by the Genetics of Personality Consortium using the -score option in PLINK, which computes a linear function of the additively coded reference alleles weighted by the log odds ratio estimates from the relevant GWAS. As noted earlier, PRSs are computed using specified P-value thresholds. Since there is no a priori method to determine which threshold yields the most predictive score, we examined PTSD using six different P-value thresholds representing a range of polygenicity: P < .05, P < .10, P < .20, P < .30, P < .40, and P < .50.
Statistical analysis
The R (http://www.R-project.org) and SPSS, version 22 (IBM Corp., Armonk, NY) platforms were used for statistical analyses. Analyses examining the relationships between neuroticism, anxiety, major depressive disorder, or cross-disorder PRSs and DMN connectivity were conducted using hierarchal linear regression models. Models were run separately for each respective PRS (i.e., neuroticism, anxiety, major depressive disorder, or cross-disorder), in which the eight functional connectivity variables (four for each hemisphere) were regressed onto PTSD symptom severity, along with covariates of age, sex, the first three ancestry substructure principal components, and alcohol use. In each model, the six PRS thresholds for each respective trait and each PTSD severity by PRS (at the six different thresholds) interaction were evaluated in six separate regressions (one for each P-value threshold). A Monte-Carlo null simulation with 10,000
replicates in which PRSs were randomly permuted between subjects was used to compute multiple-testing corrected significance for each model. This procedure adjusted for the six PRS thresholds examined while accounting for the correlations between the eight functional connectivity measures. 1 We then performed secondary analyses using the PRS thresholds that showed the strongest interaction with PTSD symptom severity. Secondary analyses examined whether TBI diagnosis, number of TBIs, or trauma exposure accounted for the relationship between PTSD symptom severity, functional connectivity and polygenic risk using the same approach. We also tested the main effects and interactions with polygenic risk of TBI diagnosis, number of TBIs, and trauma exposure on functional connectivity for the strongest polygenic risk threshold by PTSD symptom severity interactions.
RESULTS
Results revealed a significant interaction between PTSD symptom severity and cross-disorder polygenic risk on DMN connectivity between the PCC and right middle temporal gyrus at the P < .05 and 0.10 thresholds (P < .05 threshold: B = −.0007, P = .0009, corrected P < .02; P < .10 threshold: B = −.0005, P = .0006, corrected P = .01), such that at higher levels of cross-disorder polygenic risk there was a stronger negative relationship between PTSD symptom severity and functional connectivity. To further examine the nature of the interaction between crossdisorder polygenic risk and PTSD symptom severity with connectivity between the PCC and right middle temporal gyrus, we performed
Pearson correlations in which we divided the sample into two groups based on cross-disorder polygenic risk using a median split (low and high polygenic risk). Results revealed a significant negative correlation for the high cross-disorder risk group using both the P < .05
(r = −.3, P = .02; Fig. 2A ) and P < .10 (r = −.3, P = .01; Fig. 2B ) thresholds, indicating that those with high cross-disorder polygenic risk and severe PTSD symptoms showed reduced functional connectivity between the PCC and right middle temporal gyrus. There were no significant associations in the low cross-disorder risk group at either threshold (P < .05 threshold: r = .2, P = .1; Fig. 2A ; P < .10 threshold: r = .2, P = .1; Fig. 2B ).
Finally, to determine whether TBI (diagnosis or number of TBIs)
or trauma exposure accounted for the observed association between PTSD symptom severity, cross-disorder polygenic risk, and functional connectivity between the PCC and right middle temporal gyrus, we performed a series of analyses that included the main effects of TBI diagnosis, number of TBIs, or trauma exposure in the model. The pattern of results did not change (see Supporting Information Tables S2,   S3 , and S4). Moreover, none of these variables independently contributed to the variance explained in the connectivity between PCC and right middle temporal gyrus. We also examined whether there was an interaction between cross-disorder polygenic risk and these 
DISCUSSION
This study used PRSs to examine genomic sources of variation in patterns of neural network connectivity associated with PTSD. On the basis of previous twin, personality, and molecular genetic GWAS studies suggesting that broad classes of psychiatric disorders share common genetic vulnerabilities, we examined PRSs for neuroticism, anxiety, major depressive disorder, and cross-disorder. Analyses revealed that cross-disorder polygenic risk significantly moderated the relationship between PTSD symptom severity and DMN connectivity, such that individuals at high cross-disorder genetic risk and severe PTSD symptoms showed reduced functional connectivity between the PCC and right middle temporal gyrus. PRSs for neuroticism, anxiety, and major depressive disorder were not significantly associated with DMN functional connectivity. Moreover, secondary analyses showed that the DMN connectivity effects were not attributable to TBI or trauma exposure. These results align with findings of recent studies suggesting that a broad spectrum of psychiatric disorders may be influenced Our finding of reduced DMN connectivity between the PCC and middle temporal gyrus in a subset of patients with PTSD is consistent with prior rs-fMRI studies (Kennis et al., 2016; Koch et al., 2016; Sripada et al., 2012; Zhou et al., 2012) . The PCC is widely implicated in self-monitoring and self-reflection (Johnson et al., 2002; Vogt & Laureys, 2005) and previous studies have found disrupted connectivity between this region and the middle temporal gyrus in patients with PTSD (Bluhm et al., 2009; Qin et al., 2012) . The middle temporal gyrus is part of the dorsal medial prefrontal cortex subsystem of the DMN, which is associated with self-referential judgments and the present F I G U R E 2 Cross-disorder polygenic risk influences DMN functional connectivity in those with greater PTSD symptom severity. There was a significant interaction between PTSD symptom severity and cross-disorder polygenic risk score at both P < .05 and .10 thresholds for DMN functional connectivity. Individuals with high cross-disorder polygenic risk (as determined by a median split) at (A) the P < .05 threshold and (B) the P < .10 threshold had reduced functional connectivity between the PCC and the right middle temporal gyrus with increasing PTSD symptom severity. There was no significant association between PTSD symptom severity and PCC and right middle temporal gyrus connectivity with low crossdisorder polygenic risk at either threshold. DMN, default mode network; PCC, posterior cingulate cortex; PTSD, posttraumatic stress disorder; R, right mental state (Andrews-Hanna et al., 2010) . Disrupted self-referential processing is a common clinical presentation of many psychiatric disorders, including major depressive disorder, autism spectrum disorder, and schizophrenia (Bora, Yucel, & Pantelis, 2009; Harvey, Lee, Horan, Ochsner, & Green, 2011; Lombardo, Barnes, Wheelwright, & BaronCohen, 2007; Mor & Winquist, 2002) . Therefore, it is possible that altered functional connectivity in a DMN subsystem important for self-referential processing might act as a mechanism for shared clinical symptoms between PTSD and its comorbidities in individuals with severe PTSD and high cross-disorder genetic risk. This interpretation of our findings suggests that genetic vulnerability to psychopathology in combination with severe PTSD symptoms may place an individual at greater risk for comorbid disorders via this DMN mechanism. However, more research is needed to confirm this hypothesis.
As illustrated in Figure Interestingly, we did not find any main effects of PTSD symptom severity or PRSs on DMN connectivity. This is in contrast to previous studies that have found significant PTSD effects on DMN connectivity (Bluhm et al., 2009; Kennis et al., 2016; Koch et al., 2016; Qin et al., 2012; Sripada et al., 2012; Zhou et al., 2012) , but is consistent with a recent study that reported no PTSD group differences in DMN connectivity (Reuveni et al., 2016) . Recent work by Miller et al. (2017) suggests that PTSD is associated with specific disruptions in the medial temporal lobe subsystem of the DMN, which includes regions such as the hippocampus and ventromedial prefrontal cortex. It is possible that the absence of a bivariate association between PTSD and DMN connectivity in the current study is related to this reported specificity of DMN alterations in PTSD, which was not tested here. Another possibility is that individual differences in genetics play a role in moderating the association between PTSD and DMN connectivity, which thereby limits bivariate associations between the two directly. This is consistent with our previous work (Miller et al., 2016) and highlights the importance of genetic factors in PTSD-associated neural outcomes.
To our knowledge, this is the first study to examine the association between DMN connectivity and PRSs of neuroticism, anxiety, depression, and cross-disorder. Our results suggest that genetic risk for these disorders alone may not be sufficient for disruptions in functional connectivity, but instead may require additional vulnerabilities such as severe PTSD. However, it will be important for future work to confirm these results.
These findings should be considered in light of several limitations. error. However, we used multiple comparison correction in our initial analyses of DMN connectivity and polygenic risk to reduce the likelihood of this increase in error. Moreover, these analyses were comparable to previously published work with similar sample sizes investigating genetics, clinical disorders, and neuroimaging measures (Costafreda et al., 2013; Hayes et al., 2017; Miller et al., 2016; Miller et al., 2015; Whitwell et al., 2012) . Nonetheless, it will be important for other studies with larger sample sizes to replicate these findings.
CONCLUSION
We examined PRSs of PTSD-related traits to advance the understanding of the relationship between PTSD and a hypothesized neural endophenotype of the disorder, disrupted DMN connectivity. Our findings contribute to a growing body of literature on rs-fMRI in PTSD and suggest that individual differences in genetic risk for psychopathology may modify the association between PTSD symptom severity and DMN connectivity. The present findings illustrate the potential power of genome-wide PRSs to advance understanding of the relationship between psychiatric disorders and the putative neural endophenotypes of those conditions. 
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